CA2268022A1 - Galectin 8, 9, 10 and 10sv - Google Patents

Galectin 8, 9, 10 and 10sv Download PDF

Info

Publication number
CA2268022A1
CA2268022A1 CA002268022A CA2268022A CA2268022A1 CA 2268022 A1 CA2268022 A1 CA 2268022A1 CA 002268022 A CA002268022 A CA 002268022A CA 2268022 A CA2268022 A CA 2268022A CA 2268022 A1 CA2268022 A1 CA 2268022A1
Authority
CA
Canada
Prior art keywords
seq
gly
galectin
leu
val
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002268022A
Other languages
English (en)
French (fr)
Inventor
Jian Ni
Reiner L. Gentz
Steven M. Ruben
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2268022A1 publication Critical patent/CA2268022A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4726—Lectins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4724—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Transplantation (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Rheumatology (AREA)
  • General Physics & Mathematics (AREA)
CA002268022A 1996-10-09 1997-10-09 Galectin 8, 9, 10 and 10sv Abandoned CA2268022A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2809396P 1996-10-09 1996-10-09
US60/028,093 1996-10-09
USPCT/US96/16565 1996-10-09
US9616565 1996-10-09
PCT/US1997/018261 WO1998015624A1 (en) 1996-10-09 1997-10-09 Galectin 8, 9, 10 and 10sv

Publications (1)

Publication Number Publication Date
CA2268022A1 true CA2268022A1 (en) 1998-04-16

Family

ID=26703285

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002268022A Abandoned CA2268022A1 (en) 1996-10-09 1997-10-09 Galectin 8, 9, 10 and 10sv

Country Status (4)

Country Link
EP (1) EP1012266A4 (https=)
JP (1) JP2001501831A (https=)
CA (1) CA2268022A1 (https=)
WO (1) WO1998015624A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1311693A (zh) * 1998-06-03 2001-09-05 株式会社效应性细胞研究所 嗜酸性粒细胞趋化因子
CN1302881A (zh) 1999-10-28 2001-07-11 上海博容基因开发有限公司 一种新的多肽——人β－半乳糖苷结合蛋白和编码这种多肽的多核苷酸
US6953658B2 (en) 2000-03-09 2005-10-11 Diadexus, Inc. Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
AU2002214256B2 (en) * 2000-11-01 2007-07-12 Galpharma Co., Ltd. Agent for detecting cancer's ability to metastasize
WO2003072606A2 (en) * 2002-02-28 2003-09-04 Yeda Research And Development Company Ltd. Galectin-8and functional derivatives as binding agents for cd44 glycoproteins and methods of use
US20030165965A1 (en) * 2002-03-01 2003-09-04 Helen Francis-Lang LGALS as modifiers of the CHK pathway and methods of use
US20060009378A1 (en) 2002-11-14 2006-01-12 Itshak Golan Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
WO2004043332A2 (en) * 2002-11-14 2004-05-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
US20060134119A1 (en) * 2003-01-24 2006-06-22 Mitsuomi Hirashima Drugs containing galectin 9
US20070042941A1 (en) * 2003-04-28 2007-02-22 Mitsuomi Hirashima Galectin 9-inducing factors
DE10333406A1 (de) * 2003-07-15 2005-02-10 Protagen Ag T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen
CA2541006C (en) * 2003-10-03 2015-02-17 Brigham And Women's Hospital Tim-3 polypeptides
TW200539890A (en) 2004-03-12 2005-12-16 Brigham & Womens Hospital Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
JP4792390B2 (ja) * 2004-03-29 2011-10-12 株式会社ガルファーマ 新規ガレクチン９改変体タンパク質及びその用途
EP1767634A4 (en) * 2004-06-14 2008-10-22 Galpharma Co Ltd NEW GALECTIN 8 MODIFICATION PROTEIN AND USE THEREOF
CN1332030C (zh) * 2005-04-28 2007-08-15 武汉大学 一种真菌半乳糖凝集素蛋白活性的多肽、其编码序列及制备方法和应用
JP2007131540A (ja) * 2005-11-08 2007-05-31 Galpharma Co Ltd Ｃｄ４４機能抑制因子による抗アレルギー薬、免疫抑制薬および抗腫瘍薬
CN102205111B (zh) * 2011-05-19 2013-01-23 武汉大学 杨树菇半乳糖凝集素在制备抗hiv感染药物中的用途
WO2014171018A1 (ja) * 2013-04-20 2014-10-23 株式会社ガルファーマ 疾患の診断方法、疾患の治療または予防方法、疾患の診断用キット、疾患の治療または予防用医薬
JP5420791B1 (ja) * 2013-08-23 2014-02-19 肇 福永 サルモネラ菌及びシート状ｍ細胞
IL314040A (en) * 2016-05-10 2024-09-01 Genentech Inc Methods of decreasing trisulfide bonds during recombinant production of polypeptides
JP7224583B2 (ja) * 2018-01-29 2023-02-20 日本メナード化粧品株式会社 ガレクチン－９産生促進剤
CN108409850A (zh) * 2018-01-30 2018-08-17 河南师范大学 一种鱼源半乳糖凝集素CaGal重组蛋白的制备方法及其应用
CN113999287B (zh) * 2021-12-02 2023-06-27 深圳湾实验室坪山生物医药研发转化中心 一种靶向半乳糖凝集素-10的多肽抑制剂及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5851764A (en) * 1990-10-25 1998-12-22 The Trustees Of Columbia University In The City Of New York Human prostate tumor inducing gene-1 and uses thereof
WO1996039419A1 (en) * 1995-06-06 1996-12-12 Human Genome Sciences, Inc. Colon specific genes and proteins
EP0841393A4 (en) * 1995-07-11 1998-11-11 Sagami Chem Res HUMAN GALECTIN-4-LIKE PROTEIN AND ENCODING DNA

Also Published As

Publication number Publication date
EP1012266A4 (en) 2004-04-28
WO1998015624A1 (en) 1998-04-16
EP1012266A1 (en) 2000-06-28
JP2001501831A (ja) 2001-02-13

Similar Documents

Publication Publication Date Title
CA2268022A1 (en) Galectin 8, 9, 10 and 10sv
US7223840B2 (en) Antimicrobial peptide
US8017349B2 (en) Human neuronal attachment factor-1
KR20030096450A (ko) 고사 유도 분자 ⅱ
WO1998015624A9 (en) Galectin 8, 9, 10 and 10sv
EP0929575A1 (en) Novel human growth factors
US6468768B1 (en) Galectin 9 and 10SV polynucleotides
AU750170B2 (en) Caspase-14 polypeptides
US6232100B1 (en) Cortistatin Polypeptides
WO1996035703A1 (en) Human inhibitor of apoptosis gene 1
WO1998053069A2 (en) Gdnf receptors
US20030166898A1 (en) Myelin oligodendrocyte glycoprotein-like protein (MOGp)
WO1998029438A9 (en) Cortistatin polypeptides
US7109306B2 (en) Antibodies to human oncogene induced secreted protein I
CA2336406A1 (en) Galectin 11
AU734384B2 (en) Apoptosis inducing molecule II
US6689360B2 (en) Human B-cell translocation genes-2 and 3 antibodies
AU771013B2 (en) Apoptosis inducing molecule II
CA2266425A1 (en) Human b-cell translocation genes-2 and 3
WO1998012204A9 (en) Human b-cell translocation genes-2 and 3
AU2004202460A1 (en) Apoptosis Inducing Molecule II
CA2402839A1 (en) Galectin 11

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead